» Articles » PMID: 33894563

Mapping Protein-protein Interactions in Homodimeric CYP102A1 by Crosslinking and Mass Spectrometry

Overview
Journal Biophys Chem
Specialty Biochemistry
Date 2021 Apr 24
PMID 33894563
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Covalent crosslinking and mass spectrometry techniques hold great potential in the study of multiprotein complexes, but a major challenge is the inability to differentiate intra- and inter- protein crosslinks in homomeric complexes. In the current study we use CYP102A1, a well-characterized homodimeric P450, to examine a subtractive method that utilizes limited crosslinking with disuccinimidyl dibutyric urea (DSBU) and isolation of the monomer, in addition to the crosslinked dimer, to identify inter-monomer crosslinks. The utility of this approach was examined with the use of MS-cleavable crosslinker DSBU and recently published cryo-EM based structures of the CYP102A1 homodimer. Of the 31 unique crosslinks found, 26 could be fit to the reported structures whereas 5 exceeded the spatial constraints. Not only did these crosslinks validate the cryo-EM structure, they point to new conformations of CYP102A1 that bring the flavins in closer proximity to the heme.

Citing Articles

Probing Protein Dynamics in Neuronal Nitric Oxide Synthase by Quantitative Cross-Linking Mass Spectrometry.

Jiang T, Wan G, Zhang H, Gyawali Y, Underbakke E, Feng C Biochemistry. 2023; 62(15):2232-2237.

PMID: 37459398 PMC: 10529231. DOI: 10.1021/acs.biochem.3c00245.


Biochemically validated structural model of the 15-subunit intraflagellar transport complex IFT-B.

Petriman N, Loureiro-Lopez M, Taschner M, Zacharia N, Georgieva M, Boegholm N EMBO J. 2022; 41(24):e112440.

PMID: 36354106 PMC: 9753473. DOI: 10.15252/embj.2022112440.


Confrontation of AlphaFold models with experimental structures enlightens conformational dynamics supporting CYP102A1 functions.

Urban P, Pompon D Sci Rep. 2022; 12(1):15982.

PMID: 36155638 PMC: 9510131. DOI: 10.1038/s41598-022-20390-6.

References
1.
Munro A, Leys D, McLean K, Marshall K, Ost T, Daff S . P450 BM3: the very model of a modern flavocytochrome. Trends Biochem Sci. 2002; 27(5):250-7. DOI: 10.1016/s0968-0004(02)02086-8. View

2.
Jeffreys L, Pacholarz K, Johannissen L, Girvan H, Barran P, Voice M . Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches. J Biol Chem. 2020; 295(22):7595-7607. PMC: 7261786. DOI: 10.1074/jbc.RA119.011630. View

3.
Neeli R, Girvan H, Lawrence A, Warren M, Leys D, Scrutton N . The dimeric form of flavocytochrome P450 BM3 is catalytically functional as a fatty acid hydroxylase. FEBS Lett. 2005; 579(25):5582-8. DOI: 10.1016/j.febslet.2005.09.023. View

4.
Sevrioukova I, Hazzard J, Tollin G, Poulos T . The FMN to heme electron transfer in cytochrome P450BM-3. Effect of chemical modification of cysteines engineered at the FMN-heme domain interaction site. J Biol Chem. 1999; 274(51):36097-106. DOI: 10.1074/jbc.274.51.36097. View

5.
Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C . Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell. 2013; 152(1-2):276-89. DOI: 10.1016/j.cell.2012.11.048. View